Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
886.6 DKK | +2.28% | +2.36% | +27.00% |
Apr. 25 | NOVO NORDISK : JP Morgan gives a Buy rating | ZD |
Apr. 25 | Scholz promises support for pharma sector in Germany as Merck invests | RE |
Sales 2024 * | 287B 41.21B | Sales 2025 * | 346B 49.58B | Capitalization | 3,955B 567B |
---|---|---|---|---|---|
Net income 2024 * | 104B 14.85B | Net income 2025 * | 125B 17.9B | EV / Sales 2024 * | 13.8 x |
Net Debt 2024 * | 23.85B 3.42B | Net cash position 2025 * | 348M 49.96M | EV / Sales 2025 * | 11.4 x |
P/E ratio 2024 * |
37.5
x | P/E ratio 2025 * |
30.9
x | Employees | 63,845 |
Yield 2024 * |
1.36% | Yield 2025 * |
1.62% | Free-Float | 70.47% |
Latest transcript on Novo Nordisk A/S
1 day | +2.28% | ||
1 week | +2.77% | ||
Current month | +0.60% | ||
1 month | -0.88% | ||
3 months | +22.48% | ||
6 months | +28.05% | ||
Current year | +27.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 90-12-31 | |
Director of Finance/CFO | 53 | 98-12-31 | |
Stephen Gough
CTO | Chief Tech/Sci/R&D Officer | - | 15-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 63 | 15-03-18 |
Helge Lund
CHM | Chairman | 61 | 17-03-22 |
Martin MacKay
BRD | Director/Board Member | 68 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
21.31% | 192 M€ | +13.43% | ||
10.45% | 5 M€ | +8.63% | ||
5.40% | 18 M€ | +3.79% | - | |
4.67% | 88 M€ | +10.37% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 886.6 | +2.28% | 2,082,169 |
24-04-25 | 866.8 | -1.35% | 2,439,240 |
24-04-24 | 878.7 | -1.41% | 1,877,505 |
24-04-23 | 891.3 | +1.83% | 1,866,811 |
24-04-22 | 875.3 | +1.05% | 2,031,675 |
Delayed Quote Nasdaq Copenhagen, April 26, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.00% | 556B | |
+25.83% | 653B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B | |
-11.77% | 143B |
- Stock Market
- Equities
- NOVO B Stock